Revenue increased 16.7%
Revenue changed +16.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +16.7% from the comparable as-filed period.
Gross profit changed +22.3% from the comparable as-filed period.
Free-cash-flow proxy changed +14.7% from the comparable as-filed period.
Research & development changed +18.9% from the comparable as-filed period.
Capex / revenue changed +142 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +600 basis points from the comparable as-filed period.
Debt / assets changed -2030 basis points from the comparable as-filed period.
Debt / revenue changed -12566 basis points from the comparable as-filed period.
Working capital / assets changed +1196 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed +6.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash / debt changed +234 basis points from the comparable as-filed period.
SBC / revenue changed -78 basis points from the comparable as-filed period.
Inventory changed -10.0% from the comparable as-filed period.
Shares outstanding changed +2.5% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Current assets changed -4.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cost of revenue changed +11.0% from the comparable as-filed period.
Stock-based compensation changed +10.7% from the comparable as-filed period.
Operating cash-flow margin changed +110 basis points from the comparable as-filed period.
R&D / revenue changed +51 basis points from the comparable as-filed period.
Free-cash-flow margin changed -32 basis points from the comparable as-filed period.
Noncurrent long-term debt changed +0.8% from the comparable as-filed period.
Capital expenditure changed -63.0% from the comparable as-filed period.
Gross margin changed +79 basis points from the comparable as-filed period.
Research & development changed +18.7% from the comparable as-filed period.
SBC / revenue changed +173 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -71.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash-flow margin changed -543 basis points from the comparable as-filed period.
Receivables / revenue changed +930 basis points from the comparable as-filed period.
Working capital / assets changed -2326 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +10.7% from the comparable as-filed period.
Free-cash-flow proxy changed +6.8% from the comparable as-filed period.
Stock-based compensation changed +25.1% from the comparable as-filed period.
Operating income changed -3.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -6.7% from the comparable as-filed period.
Current assets changed -12.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +12.2% from the comparable as-filed period.
Total assets changed +5.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +5.0% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Cash & equivalents changed -9.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed +182 basis points from the comparable as-filed period.
Inventory changed -4.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cost of revenue changed +8.6% from the comparable as-filed period.
Free-cash-flow margin changed -98 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.